Grace Life-tech Holdings Limited (HK:2112) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Grace Life-tech Holdings Limited has announced a strategic cooperation with Tianjin Bingcao Gangmu Biotechnology Co., Ltd. to expand their health industry footprint using plant cambium stem cell technology. The partnership aims to capitalize on Bingcao Gangmu’s extensive sales network and smart health management system, with expectations to open over 1,000 health management centers and achieve over RMB 1 billion in sales by 2024. This collaboration is set to enhance Grace Life-tech’s market presence and foster growth in the plant stem cell industry.
For further insights into HK:2112 stock, check out TipRanks’ Stock Analysis page.